Home Search

breast cancer - search results

If you're not happy with the results, please do another search
Team of scientists working on a research in laboratory.

‘AI scientist’ finds common drug combinations can kill breast cancer cells

An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
Microscopy image of invasive breast cancer cells (labelled in yellow) degrading their underlying extracellular matrix (labelled gelatin in red, degraded areas appear as black holes). Scale bar, 20µm. Credit Omkar Joshi / Turku Bioscience Centre, University of Turku

New visualisation tool ‘Illusia’ helps researchers target how breast cancer spreads

A new visualisation tool is shedding light on breast cancer spread. This innovative fluorescent probe, called Illusia, allows researchers to observe dynamic signalling within moving cancer cells, potentially opening new avenues for treatment and preventing metastatic spread.
Calm patient and infusion

Breakthrough in treating aggressive breast cancer improves patient survival

A new treatment approach for aggressive breast cancers significantly improves survival rates for patients.
Female cancer patient shares symptoms with cheerful female doctor

NHS breast cancer screening campaign gains an impressive amount of engagement

After the NHS announced the launch of their first ever breast cancer screening campaign, tens of thousands of women have been accessing vital advice on attending mammograms.
Breast cancer awareness hands and pink ribbon flat card design

Record numbers are attending breast cancer screening, but thousands still miss appointments

According to the latest NHS England figures, a record number of women are up to date with their breast screenings. However, many of those invited are still not attending their appointments.
Young woman is having mammography examination at the hospital or private clinic with a professional female doctor.

AI trials to help with early breast cancer detection

The UK government is starting a breast cancer trial to test how AI can be used to detect breast cancer early.
Figure 1. Personalized medicine in RESCUER. From bottom left. Clinical and molecular data are collected from clinical trials from Norway, Germany and Spain and processed to identify signatures/ molecular barcodes of resistance to hormonal-, immune-, and chemotherapy, respectively. Pathological images are subjected to digital cartography and together with the molecular barcodes used for patient stratification towards improved treatment strategies. The generated data is used to parameterize mathematical models of prediction of treatment outcome.

Breast cancer prevention: Precision medicine and health

Biobank Norway Project experts chart the journey from precision medicine to precision health when it comes to breast cancer prevention.
Carcinoid tumors are a type of slow-growing cancer that can arise in several places throughout your body. Carcinoid tumors, which are one subset of tumors called neuroendocrine tumors, usually begin in the digestive tract (stomach, appendix, small intestine, colon, rectum) or in the lungs. Site: Ovary

How AI is being used to predict breast cancer survival durations

Hailey Coverson, Data Scientist at Bayezian, discusses the complexities of genomic data, accounting for biases and inaccuracies and AI’s potential in supporting clinical decisions in breast cancer care.
Doctor showing a chart to a patient

Breaking barriers in breast cancer treatment: The shift towards personalised care

Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.
Close-up Of Doctor Taking Blood Sample From Patient's Arm in Hospital for Medical Testing.

Blood test predicts breast cancer recurrence years in advance

In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.
FNAC of breast lump showing ductal carcinoma

Endocrine disrupting chemicals: the role they play in breast cancer

Dr Alice Di Pasquale, Scientific Research Officer at Breast Cancer UK, explains why more must be done to increase awareness of Endocrine Disrupting Chemicals and breast cancer risk.
Cute poster for breast cancer month

Breast cancer drug made accessible to 289,000 women in England

Anastrozole is to be made accessible to postmenopausal women who have a family history of breast cancer to help prevent the disease 
Close up of woman holding pink ribbon for breast cancer awarness. Detail of female hand holding pink awareness ribbon. Young woman supporting living with women's breast tumor.

RESCUER: Supporting new concepts for breast cancer subtypes treatment

RESCUER is an EU Horizon 2020 project, coordinated by the University of Oslo, Norway, that aims to predict treatment response and test new combinational therapies for complex breast cancer subtypes.
Woman holding pink ribbon on white background, top view with space for text. Breast cancer awareness concept

How to recognise less common breast cancer symptoms

October is dedicated to raising awareness for breast cancer. A recent study highlights the need for more education into the less common symptoms of breast cancer.
breast device article

Cutting-edge robot holds promise for early breast cancer diagnosis

A ground breaking breast lump detection merging CBE with AI and sensors, has the potential to enhancing diagnostic methods like ultrasound.

Breast cancer survival rate sees a 66% improvement over 20 years

Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.
Volpara Scorecard image - radiologist reading

Can AI be used to predict and prevent breast cancer?

Lester Litchfield, Head of Data Science at Volpara Health, discusses the future of artificial intelligence in breast health.
breast cancer screening

Using AI to deliver high quality, personalised breast cancer screening 

Ralph Highnam, PhD, Chief Science & Innovation Officer at Volpara Health, looks at the future of breast cancer screening and the use of AI.
metastatic breast cancer, immunotherapy

Scientists use tumour-fighting cells to treat breast cancer

An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.

Follow Us

Advertisements